Patents for A61P 17 - Drugs for dermatological disorders (106,455)
07/2005
07/20/2005EP1554275A2 Compounds
07/20/2005EP1554268A1 Pyrazole inhibitors of the transforming growth factor
07/20/2005EP1554253A1 Imidazolium cxcr3 inhibitors
07/20/2005EP1553974A1 Pharmaceutical composition comprising carriers for products
07/20/2005EP1553967A1 Use of amide derivative of ge 2270 factor a3 for the treatment of acne
07/20/2005EP1553945A2 Nitroxide radioprotector formulations and methods of use
07/20/2005EP1553933A1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent
07/20/2005EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/20/2005EP1553920A1 Topical formulation for prevention and treatment of acne
07/20/2005EP1553919A1 Use of a pear must extract as active principle in a cosmetic and/or pharmaceutical composition
07/20/2005EP1553914A2 Novel cosmetic formulations based on a gel-forming and/or thickening agent and applications of same
07/20/2005EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor
07/20/2005EP1392670B1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
07/20/2005EP1303512B1 Process for preparing arylacetylaminothiazoles
07/20/2005EP1286673B8 Ligands of integrin receptors
07/20/2005EP1272484B1 Benzoamide piperidine compounds as substance p antagonists
07/20/2005EP1261328B1 Il-8 receptor antagonists
07/20/2005EP1221982B1 Isoalloxazine derivatives to neutralize biological contaminants
07/20/2005EP1198570B1 Monomeric protein of the tgf-beta family
07/20/2005EP1175402B1 Piperidine derivatives useful as ccr5 antagonists
07/20/2005EP1175401B1 Piperazine derivatives useful as ccr5 antagonists
07/20/2005EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors
07/20/2005EP1001759B1 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
07/20/2005EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis
07/20/2005EP0784430B1 Method for reducing unwanted cellular adhesions
07/20/2005CN1643140A Combination of a growth factor and a protease enzyme
07/20/2005CN1643138A Novel cytokine ZCYTOR17 ligand
07/20/2005CN1643137A Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
07/20/2005CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
07/20/2005CN1643134A Method for producing pseudo islets
07/20/2005CN1642983A Antibodies against of C5aR and use thereof
07/20/2005CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof
07/20/2005CN1642973A A method for treating allergies
07/20/2005CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof
07/20/2005CN1642959A Novel dithiolopyrrolones with therapeutic activity
07/20/2005CN1642955A Novel alkoxypyridine-derivatives
07/20/2005CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
07/20/2005CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists
07/20/2005CN1642939A Pyridinoylpiperidines as 5-HTLF agonists
07/20/2005CN1642938A New compounds
07/20/2005CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
07/20/2005CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase
07/20/2005CN1642904A Salts of nateglinide
07/20/2005CN1642902A Polyamine compounds and compositions for use in conjunction with cancer therapy
07/20/2005CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative
07/20/2005CN1642567A HIV inhibiting proteins
07/20/2005CN1642563A Compositions and methods for treatment of skin disorders
07/20/2005CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer
07/20/2005CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
07/20/2005CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
07/20/2005CN1642553A N-{'(2S) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as CCR3 antagonist for the treatment of inflammatory conditions
07/20/2005CN1642551A Inhibitors of histone deacetylase
07/20/2005CN1642550A Beta-sheet mimetics and composition and methods relating thereto
07/20/2005CN1642542A Angiogenesis inhibitors
07/20/2005CN1642538A Use of adapalene for the treatment of dermatological disorders
07/20/2005CN1642420A Dihydronepetalactone as insect repellent
07/20/2005CN1640491A Recombinant human epidermal growth factor compound biological agent and its use
07/20/2005CN1640487A Skin ointment of glossy ganoderma spore
07/20/2005CN1640476A Pox-eliminating whitening capsule
07/20/2005CN1640472A Chinesle herbal medicine liquor
07/20/2005CN1640458A Navel-moistening health-care liquor
07/20/2005CN1640455A Temperature-reducing refreshing aerosol
07/20/2005CN1640451A Medicinal composition for relieving itching
07/20/2005CN1640438A Medicine for preventing and treating nipple chap and its preparing method
07/20/2005CN1640393A Use of tea polyphenol for preparing medicine for preventing and treating lipsotrichia induced from chemotherapy
07/20/2005CN1640381A Lipsotrichia-stopping hair-growing preparation
07/20/2005CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate
07/20/2005CN1211382C Quinazoline ditosylate salt compounds
07/20/2005CN1211375C Thiazole-derivatives
07/20/2005CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them
07/20/2005CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
07/20/2005CN1211126C Vascular endothelial growth factor 2
07/20/2005CN1211115C Chinese materia medica preparation for treating burn and scald and method for preparing the same
07/20/2005CN1211102C Chinese medicine capsule for curing facial acne and preparation method
07/20/2005CN1211093C Powder prepared from snake tissues for soaking feet
07/20/2005CN1211092C External use medicine for treating bromhidrosis
07/20/2005CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same
07/20/2005CN1211079C Stable slow-releasing oral administration composition
07/20/2005CN1211072C Snake wine
07/20/2005CN1211071C Bathing disinfecting health-care preparation
07/20/2005CN1211070C Facial tissue compsn. and method of use for sequestration of nasal secretion skin irritants
07/20/2005CN1211069C Multifunctional face-beautifying Chinese medicine face mask
07/19/2005US6919432 Substances and their uses
07/19/2005US6919377 Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
07/19/2005US6919362 For use as hypoglycaemic and hypolipidaemic agents
07/19/2005US6919360 Benzisothiazolyl-substituted aminomethyl chromanes for treating diseases of the central nervous system
07/19/2005US6919354 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
07/19/2005US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
07/19/2005US6919349 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/19/2005US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents
07/19/2005US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/19/2005US6919072 Comprises matrix metalloproteinase (MMP) inhibitor; for promoting collagen production
07/15/2005WO2004068143A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
07/15/2005CA2513593A1 Use of substances inhibiting the association of smad protein with ubiquitin c-terminal hydrolase for altering cellular responses to tgf-beta or bmp
07/14/2005WO2005063725A1 Phenylpropanoic acid derivatives